CD4 and type 1 diabetes mellitus: We next tested PGLP-1-VP treatment in the NOD mouse, an excellent autoimmune diabetes model containing many characteristics of human T1DM, including genetic risk factors, the presence of pancreas-specific autoantibodies, and autoreactive CD4+ T cells45.